Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
E2F6 encodes a member of the E2F transcription factor protein family. Additionally we are shipping E2F6 Proteins (3) and E2F6 Kits (1) and many more products for this protein.
Showing 10 out of 76 products:
Human Monoclonal E2F6 Primary Antibody for ELISA, WB - ABIN393573
Cunningham, Vierkant, Sellers, Phelan, Rider, Liebow, Schildkraut, Berchuck, Couch, Wang, Fridley, Gentry-Maharaj, Menon, Hogdall, Kjaer, Whittemore, DiCioccio, Song, Gayther, Ramus, Pharaoh, Goode: Cell cycle genes and ovarian cancer susceptibility: a tagSNP analysis. in British journal of cancer 2009
Show all 5 references for ABIN393573
Human Monoclonal E2F6 Primary Antibody for IF, WB - ABIN393521
Yang, Shu, Zhu, Yang: E2F6 inhibits cobalt chloride-mimetic hypoxia-induced apoptosis through E2F1. in Molecular biology of the cell 2008
Show all 5 references for ABIN393521
Dog (Canine) Polyclonal E2F6 Primary Antibody for WB - ABIN2779510
Lazrek, Goffard, Schanen, Karquel, Bocket, Lion, Devaux, Hedouin, Gosset, Hober: Detection of hepatitis C virus antibodies and RNA among medicolegal autopsy cases in Northern France. in Diagnostic microbiology and infectious disease 2006
Show all 2 references for ABIN2779510
Cow (Bovine) Polyclonal E2F6 Primary Antibody for EIA, WB - ABIN487967
McLaughlin-Drubin, Huh, Münger: Human papillomavirus type 16 E7 oncoprotein associates with E2F6. in Journal of virology 2008
Cow (Bovine) Polyclonal E2F6 Primary Antibody for IHC, WB - ABIN2779509
Kherrouche, De Launoit, Monté: Human E2F6 is alternatively spliced to generate multiple protein isoforms. in Biochemical and biophysical research communications 2004
miR-185 suppresses tumor proliferation by directly targeting E2F6 and DNMT1 and indirectly upregulating BRCA1 in triple-negative breast cancer.
Analysis data from a panel of cell cycle transcription factors (E2F1, E2F4, E2F6, and GABPA) finds that a set of core cell cycle genes regulated in both U2OS and HeLa cells are bound by multiple cell cycle transcription factors.
After replication stress, the checkpoint kinase (show ATR Antibodies) Chk1 (show CHEK1 Antibodies) phosphorylates E2F6, leading to its dissociation from promoters. This promotes E2F (show E2F1 Antibodies)-dependent transcription, which mediates cell survival by preventing DNA damage and cell death
findings indicate an inhibitory role of E2F6 in the regulation of IL-13 (show IL13 Antibodies) and allergy
E2F6 may recruit BRG1 (show SMARCA4 Antibodies) in transcriptional regulation of genes important for G1/S phase transition of the cell cycle.
data suggest that E2F (show E2F1 Antibodies)- and Myc (show MYC Antibodies)-responsive genes are coregulated by E2F6 complex in quiescent cells
results suggest that E2F6 represses transcription of the brca1, ctip (show RBBP8 Antibodies), art27 (show UXT Antibodies), hp1alpha (show CBX5 Antibodies), and the rbap48 (show RBBP4 Antibodies) genes and depletion of E2F6 resulted in the recruitment of E2F1 (show E2F1 Antibodies) to the target promoters
contains nine exons distributed along 20.4kbp of genomic DNA on chromosome 2 leading to the transcription of six alternatively spliced E2F6 mRNAs that encode four different E2F6 proteins
E2F6 does not contain the domains required for modulation of squamous differentiation
showed that E2F6, DP1 (show PTGDR Antibodies), EPC1 (show SERPINF1 Antibodies), EZH2 (show EZH2 Antibodies), and Sin3B (show SIN3B Antibodies) co-elute, suggesting the identification of a novel E2F6 complex that exists in vivo in both normal and transformed human cell lines
These data reveal a novel interplay between the E2F pathway, beta2-adrenergic/PKA/PDE4D, and ERK/c-Src axis in fine tuning the pathological hypertrophic growth response.
E2f6 was similarly bound to the proximal promoter regions both in embryonic stem cells (ESCs (show NR2E3 Antibodies)) and epiblast stem cells (EpiSCs)
Data suggest that during development, E2F6 participates in the recruitment of polycomb (show CBX2 Antibodies) proteins to specific target promoters.
The 5' untranslated regions of E2F6 and E2F6b are unusually long, and they contain several upstream AUG codons followed by short reading frames. Our results suggest that translation of E2F6b is initiated by internal ribosome entry.
E2F6 is essential for the long-term somatic silencing of certain male-germ-cell-specific genes, but it is dispensable for cell-cycle regulation.
E2F6 silences SMC1beta (show SMC1B Antibodies) and STAG3 (show STAG3 Antibodies) in somatic cells
This analysis shows that E2f6 and Bmi1 (show BMI1 Antibodies) cooperate in the regulation of Hox (show MSH2 Antibodies) genes, and consequently axial skeleton development, but not in the repression of the Ink4a-Arf (show CDKN2A Antibodies) locus.
This gene encodes a member of the E2F transcription factor protein family. E2F family members play a crucial role in control of the cell cycle and of the action of tumor suppressor proteins. They are also a target of the transforming proteins of small DNA tumor viruses. Many E2F proteins contain several evolutionarily conserved domains: a DNA binding domain, a dimerization domain which determines interaction with the differentiation regulated transcription factor proteins (DP), a transactivation domain enriched in acidic amino acids, and a tumor suppressor protein association domain which is embedded within the transactivation domain. The encoded protein of this gene is atypical because it lacks the transactivation and tumor suppressor protein association domains. It contains a modular suppression domain and is an inhibitor of E2F-dependent transcription. The protein is part of a multimeric protein complex that contains a histone methyltransferase and the transcription factors Mga and Max. Multiple transcript variants have been reported for this gene, but it has not been clearly demonstrated that they encode valid isoforms.
E2F transcription factor 6
, transcription factor E2F6
, E2F-binding site-modulating activity protein
, transcriptional repressor E2F6